Adherence to long-term therapies: evidence for action. 1. Patient compliance. 2. Long-term care. 3. Drug therapy – utilization. 4. Chronic disease – therapy.
Adherence to Long-term Therapies: Evidence for Action: World Health Jimmy B Jose J. Patient Medication Adherence: Measures in Daily Practice.
inline supplementary material ?download=true
adherence—focused specifically on compliance with medication-related Adherence to Long-term Therapies: Policy for Action: Meeting Report 4–5 June 2001.
Adherence
recommendations” WHO ADHERENCE TO LONG-TERM THERAPIES: Evidence for action 2003. •Adherence rates with the statin therapy in elderly patients with and
GWCManifestoAdherenceChicago fullpage
Adherence to long-term therapies: evidence for action. 1. Patient compliance. 2. Long-term care. 3. Drug therapy – utilization. 4. Chronic disease – therapy
Observance moyenne (traitement au long cours) : 50% des doses prescrites D'après Sabaté E Adherence to long-term therapies: evidence for action.
jni observancebk dubee
17 déc. 2013 BMJ Open: first published as 10.1136/bmjopen-2013-003950 on 17 December ... Secondary adherence to long-term therapies: evidence for action.
e .full
slowly-to-meet-rising-strain-of-chronic-diseases.htm Source: OECD Health Statistics 2013 ... Adherence to long-term therapies: Evidence for action.
Item b Overview Community Pharmacy Services Svarcaite
medication adherence among patients with NCDs in LMICs to long-term therapy.25 26 27 The number of days during ... Action 2013;6:19658. 29. WHO.
e .full
World Health Organization (2003). Adherence to long-term therapies. Evidence for action. WHO. (Cap. XIII pp. 107-114).
pdf?md = a de ec e d aacaa&pid= s . S main